儿童急性淋巴细胞白血病患者及其护理人员对COVID-19疫苗接种的态度

相关实验视频

Updated: Jun 17, 2026

10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Janna R Shapiro^1,2,3, Gilla K Shapiro^1,4, Sumit Gupta⁵

¹Center for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.

Pediatric blood & cancer

|March 28, 2025

概括

接种急性淋巴细胞白血病 (ALL) 儿童的COVID-19疫苗需要解决知识差距和安全问题. 血液学家的建议和特定的安全数据是鼓励在这个弱势群体中接种疫苗的关键.

科学领域:

儿科瘤学儿科瘤学
疫苗学疫苗学疫苗学
公共卫生公共卫生

背景情况:

患有急性淋巴细胞白血病 (ALL) 的儿童有资格接种COVID-19疫苗.
在这一群体中,接种疫苗的决定受到独特的患者和护理人员关切的影响.
了解这些问题对于有效的疫苗接种策略至关重要.

研究的目的:

为了确定在患有ALL的儿童中接种COVID-19疫苗的障碍.
确定鼓励这一群体接种疫苗的有效策略.
为儿童ALL患者及其照顾者量身定制疫苗接种信息.

主要方法:

一项调查对被诊断患有ALL的儿童或他们的护理人员进行了调查 (N=44).
该调查旨在了解影响疫苗接种决策的因素.
确定了关键障碍和疫苗接种线索.

主要成果:

对于未接种疫苗的ALL患者的护理人员来说,缺乏关于COVID-19疫苗的知识是主要障碍.
对疫苗安全性和有效性的担忧是重要的障碍.
血液学家/瘤学家的建议成为疫苗接种的关键提示.
针对ALL儿童的疫苗安全性和有效性数据的可用性也得到了高度引用.

结论:

解决知识缺陷和安全问题对于增加儿科ALL患者COVID-19疫苗接种量至关重要.
医疗保健提供者,特别是血液学家/瘤学家,在推接种疫苗方面发挥着至关重要的作用.
为这种免疫受损人群提供量身定制的安全性和有效性数据至关重要.

关键词:

根据COVID-19的情况,急性淋巴细胞白血病急性淋巴细胞白血病决策能力决策能力健康信仰模型的模型.预防措施采用过程模型疫苗疫苗疫苗疫苗

相关概念视频

01:51

Vaccinations

Overview

02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

02:56

Treatment Resistent Cancers

01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...

01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...